Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 697 - 704 of 11617 results
OCR Releases Long Awaited Final Rule Regarding the Conscience Protections for Religious and Moral Objections in Health Care
January 29, 2024| Blog| Viewpoint
Senator's Hold on FTC Nominee Robs Agency of Political Diversity, Regulatory Attorneys Say
January 29, 2024| News
NERC Submits Work Plan for New Reliability Requirements to Apply to Inverter-Based Resources
January 26, 2024| Article| Viewpoint
What You Need to Know About FDA's Proposed Regulation of LDTs
January 26, 2024| News
Health Care Privacy and Security in 2024: Six Critical Topics to Watch
January 25, 2024| Blog| Viewpoint
ITC Blocks Imports Of TVs For Infringing AMD Patent
January 25, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.